1,​2-​Dipalmitoyl-​sn-​glycero-​3-​phosphocholine (Colfosceril Palmitate)

• CAT Number: R057043
• CAS Number: 63-89-8
• Molecular Formula: C40H80NO8P
• Molecular Weight: 734.053
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: [(2R)-2,3-di(hexadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
• InChI: InChI=1S/C40H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1
• InChIKey: KILNVBDSWZSGLL-KXQOOQHDSA-N
• SMILES: CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC

Colfosceril Palmitate(CAT: R057043), also known as 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine, is a vital compound in pharmaceuticals, specifically in the treatment of respiratory distress syndrome (RDS) in premature infants. This synthetic phospholipid derivative emulates natural lung surfactants and is utilized as an exogenous surfactant replacement therapy, effectively reducing surface tension in the lungs’ alveoli. By preventing alveolar collapse, it significantly improves respiratory function in premature infants, making it a critical and life-saving medication in neonatal care.

Reference

1: Moya FR, Gadzinowski J, Bancalari E, Salinas V, Kopelman B, Bancalari A, Kornacka MK, Merritt TA, Segal R, Schaber CJ, Tsai H, Massaro J, d/’Agostino R; International Surfaxin Collaborative Study Group. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics. 2005 Apr;115(4):1018-29. PubMed PMID: 15805380.2: Bryson HM, Whittington R. Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome. Pharmacoeconomics. 1994 Dec;6(6):563-77. PubMed PMID: 10155285.3: Backhouse ME, Mauskopf JA, Jones D, Wold DE, Schumacher R, Cotton R, Long WA. Economic outcomes of colfosceril palmitate rescue therapy in infants weighing 1250g or more with respiratory distress syndrome: results from a randomised trial. Pharmacoeconomics. 1994 Oct;6(4):358-69. PubMed PMID: 10147473.4: Dechant KL, Faulds D. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome. Drugs. 1991 Nov;42(5):877-94. Review. PubMed PMID: 1723378.5: Abrahamson EL, Viswanath M, Kovar IZ, Jawad SA. Unilateral pulmonary interstitial emphysema and treatment with colfosceril palmitate. Lancet. 1993 Jun 19;341(8860):1603. PubMed PMID: 8099684.6: Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group. Online J Curr Clin Trials. 1992 Nov 10;Doc No 28:[3886 words; 47 paragraphs]. PubMed PMID: 1343614.7: Wieland DC, Degen P, Zander T, Gayer S, Raj A, An J, Dėdinaitė A, Claesson P, Willumeit-Römer R. Structure of DPPC-hyaluronan interfacial layers – effects of molecular weight and ion composition. Soft Matter. 2016 Jan 21;12(3):729-40. doi: 10.1039/c5sm01708d. PubMed PMID: 26508354.8: Goto TE, Lopes CC, Nader HB, Silva AC, Dantas NO, Siqueira JR Jr, Caseli L. CdSe magic-sized quantum dots incorporated in biomembrane models at the air-water interface composed of components of tumorigenic and non-tumorigenic cells. Biochim Biophys Acta. 2016 Jul;1858(7 Pt A):1533-40. doi: 10.1016/j.bbamem.2016.04.009. Epub 2016 Apr 21. PubMed PMID: 27107554.9: Colfosceril palmitate (Exosurf)–artificial surfactant for immature lungs. Drug Ther Bull. 1991 Jun 10;29(12):46. PubMed PMID: 1935584.10: Bae CW, Chung SH, Choi YS. Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties. Yonsei Med J. 2016 Jan;57(1):203-8. doi: 10.3349/ymj.2016.57.1.203. PubMed PMID: 26632402; PubMed Central PMCID: PMC4696954.11: Miguel V, Defonsi Lestard ME, Tuttolomondo ME, Díaz SB, Altabef AB, Puiatti M, Pierini AB. Molecular view of the interaction of S-methyl methanethiosulfonate with DPPC bilayer. Biochim Biophys Acta. 2016 Jan;1858(1):38-46. doi: 10.1016/j.bbamem.2015.10.008. Epub 2015 Oct 23. PubMed PMID: 26476106.12: Rosa AS, Cutro AC, Frías MA, Disalvo EA. Interaction of Phenylalanine with DPPC Model Membranes: More Than a Hydrophobic Interaction. J Phys Chem B. 2015 Dec 31;119(52):15844-7. doi: 10.1021/acs.jpcb.5b08490. Epub 2015 Dec 18. PubMed PMID: 26636175.13: Pierrat P, Lebeau L. Characterization of Titratable Amphiphiles in Lipid Membranes by Fluorescence Spectroscopy. Langmuir. 2015 Nov 17;31(45):12362-71. doi: 10.1021/acs.langmuir.5b03258. Epub 2015 Nov 4. PubMed PMID: 26507074.14: Mukai M, Krause MR, Regen SL. Peptide Recognition of Cholesterol in Fluid Phospholipid Bilayers. J Am Chem Soc. 2015 Oct 7;137(39):12518-20. doi: 10.1021/jacs.5b08132. Epub 2015 Sep 25. PubMed PMID: 26394115.15: Kardash ME, Isaev NP, Dzuba SA. Heterogeneities in Cholesterol-Containing Model Membranes Observed by Pulsed Electron Paramagnetic Resonance of Spin Labels. J Phys Chem B. 2015 Oct 29;119(43):13675-9. doi: 10.1021/acs.jpcb.5b03080. Epub 2015 May 20. PubMed PMID: 25965099.